|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Product revenue, net | |||||
| Product revenue, net | |||||
| Other revenue | |||||
| Total product revenue, net | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain on marketable securities | |||||
| Foreign currency translation adjustment | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive loss | |||||
| Per share information: | |||||
| Net loss per share, basic (in USD per share) | |||||
| Net loss per share, diluted (in USD per share) | |||||
| Weighted-average shares used in computing net loss per share, basic (in shares) | |||||
| Weighted-average shares used in computing net loss per share, diluted (in shares) | |||||
Loading...